Acorah Software Products - Accounts Production 16.2.850 true true false 20 September 2023 30 September 2024 30 September 2024 15149682 Ayomide Akintibu iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15149682 2023-09-19 15149682 2024-09-30 15149682 2023-09-20 2024-09-30 15149682 frs-core:CurrentFinancialInstruments 2024-09-30 15149682 frs-core:ShareCapital 2024-09-30 15149682 frs-bus:PrivateLimitedCompanyLtd 2023-09-20 2024-09-30 15149682 frs-bus:FilletedAccounts 2023-09-20 2024-09-30 15149682 frs-bus:SmallEntities 2023-09-20 2024-09-30 15149682 frs-bus:EntityHasNeverTraded 2023-09-20 2024-09-30 15149682 frs-bus:AuditExempt-NoAccountantsReport 2023-09-20 2024-09-30 15149682 frs-bus:SmallCompaniesRegimeForAccounts 2023-09-20 2024-09-30 15149682 frs-bus:Director1 2023-09-20 2024-09-30 15149682 frs-countries:EnglandWales 2023-09-20 2024-09-30
Registered number: 15149682
Gatco Chempharm (UK) Ltd
Unaudited Financial Statements
For the Period 20 September 2023 to 30 September 2024
Wizz Accounting Ltd
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 15149682
30 September 2024
Notes £ £
CURRENT ASSETS
Debtors 4 351
351
NET CURRENT ASSETS (LIABILITIES) 351
TOTAL ASSETS LESS CURRENT LIABILITIES 351
NET ASSETS 351
CAPITAL AND RESERVES
Called up share capital 5 351
SHAREHOLDERS' FUNDS 351
For the period ending 30 September 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Ayomide Akintibu
Director
29 July 2025
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Gatco Chempharm (UK) Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15149682 . The registered office is 128 City Road, London, EC1V 2NX.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
4. Debtors
30 September 2024
£
Due within one year
Other debtors 351
5. Share Capital
30 September 2024
£
Called Up Share Capital not Paid 351
Amount of Allotted, Called Up Share Capital 351
Page 2